Envista Holdings Corp
0HV.DE
Deutsche Börse39.73
EUR
- -
- -
Envista Holdings Corp
0HV.DE
(Deutsche Börse)
Recent
price
39.73
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Envista Holdings Corporation (NYSE: NVST; 0HV.DE) develops, manufactures, and markets dental products worldwide. The company offers a comprehensive portfolio of consumables, equipment, and digital solutions for dental professionals, including implants and biomaterials through the Nobel Biocare brand; restorative and aesthetic solutions via Kerr; endodontic products under Endo; orthodontics with Ormco; and digital imaging and CAD/CAM systems through KaVo Kerr. It serves dentists, orthodontists, oral surgeons, and laboratories in over 100 countries from its headquarters in Brea, California, where it was spun off from Danaher Corporation in 2019. Envista operates through two main segments: Specialty Products & Technologies, which includes implants, orthodontics, and digital dentistry; and Equipment & Consumables, covering restorative, endodontic, and imaging products. Recent developments include the October 2024 launch of the Atlantis Next generation digital abutment system, enhancing patient-specific prosthetics; the acquisition of Periodontix in March 2024 to bolster regenerative therapy offerings; and a strategic partnership with PDS Health announced in late 2024 to expand distribution in the U.S. dental service organization market. In 2025, Envista reorganized its leadership with new executive appointments to drive digital innovation amid competitive pressures in the global dental consumables sector.